DAFNA Capital Management LLC
Position in IDYA — IDEAYA Biosciences, Inc.
CIK 1389933
LOS ANGELES, CA
Position in IDYA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,532,134
+$2,647,158 QoQ
Shares Held
497,240
+4.3% QoQ
Ownership
0.515%
of shares outstanding
% of Portfolio
3.76%
of 13F equity value
Holder Rank
#37
of 282 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. IDYA ranks #4 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
This page
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in IDYA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,532,134 | 497,240 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,884,976 | 476,740 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,518,001 | 506,740 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,691,304 | 539,923 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,013,271 | 619,090 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,653,225 | 589,330 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,819,853 | 498,827 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,934,268 | 471,410 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,823,898 | 422,213 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $19,585,443 | 446,341 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $18,371,412 | 516,341 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,485,143 | 499,820 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,275,770 | 479,820 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,430,555 | 468,358 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,510,064 | 468,358 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,035,330 | 538,561 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,570,141 | 548,561 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,483,782 | 490,061 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,875,842 | 460,061 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,726,954 | 460,061 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,961,564 | 331,661 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,794,033 | 331,661 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,643,254 | 331,661 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,165,662 | 331,661 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||